MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:
MJAR), a leader in cannabis management, today announced the closing of
its acquisition of GrowForce Holdings Inc. (“GrowForce”), a
vertically integrated international cannabis platform headquartered in
Toronto and the release to the Company of the net proceeds of
GrowForce’s July 2018 subscription receipt financing.

The transactions were completed after the closing of markets on November
30, 2018. After reflecting those subscription receipts that were
redeemed as part of closing, GrowForce raised gross proceeds of $34.7
million of new equity in its July 2018 subscription receipt offering. In
connection with the acquisition of GrowForce by the Company,
approximately 30 million MJardin common shares were issued or will
become issuable upon the exercise of certain previously issued GrowForce
options and warrants.

“With the closing of this strategic transaction, MJardin is well
positioned to continue to grow our global footprint of managed and owned
facilities,” said Rishi Gautam, Chairman and Chief Executive Officer of
MJardin Group. “MJardin now has one the largest international footprints
of any cannabis provider and we intend to leverage our scale for
continued growth both organically and through strategic acquisitions of
cannabis assets in the U.S., Canada, Europe, Africa and Latin America.”

KES 7 Capital Inc. and Cormark Securities acted as the financial
advisors to the board of directors of GrowForce, who also received an
updated independent fairness opinion from GMP Securities. WeirFoulds LLP
acted as legal counsel to GrowForce.

About MJardin Group

MJardin is a global cannabis management platform with extensive
experience in cultivation, processing, distribution and retail. For over
10 years, MJardin has refined cultivation methodologies, developed state
of the art facilities and implemented vertical integration for and on
behalf of license owners. As a well-capitalized organization, MJardin
continues to pursue strategic expansion and M&A opportunities across
global legal cannabis markets. MJardin is based in Denver Colorado, with
offices in Toronto, Canada and Barcelona, Spain. For more information,
please visit www.mjardin.com.

The CSE has not in any way passed upon the merits of the proposed
acquisition, and has neither approved nor disapproved the contents of
this news release.

This news release does not constitute an offer to sell or a
solicitation of an offer to sell any of the securities in the United
States. The securities have not been and will not be registered under
the United States Securities Act of 1933, as amended (the “U.S.
Securities Act”) or any state securities laws and may not be offered
or sold within the United States or to U.S. Persons unless registered
under the U.S. Securities Act and applicable state securities laws or an
exemption from such registration is available.

Forward-Looking Information

This news release contains forward-looking information based on
current expectations. Statements about, among other things, future
developments and the business and operations of MJardin and GrowForce,
the growth of or global footprint and our intentions to leverage our
scale for continued organic growth and to pursue strategic acquisitions
are all forward-looking information. These statements should not be read
as guarantees of future performance or results. Such statements involve
known and unknown risks, uncertainties and other factors that may cause
actual results, performance or achievements to be materially different
from those implied by such statements. Such factors include, but are not
limited to: our ability to integrate both companies, our ability to
identify and pursue growth, financing and other strategic objectives,
and the regulatory and economic environments in the jurisdictions we
operate or intend to operate or investment in. Although such statements
are based on management’s reasonable assumptions at the date such
statements are made, there can be no assurance that the proposed
acquisition will occur and that such forward-looking information will
prove to be accurate, as actual results and future events could differ
materially from those anticipated in such forward-looking information.
Accordingly, readers should not place undue reliance on the
forward-looking information. MJardin assumes no responsibility to update
or revise forward-looking information to reflect new events or
circumstances unless required by applicable law.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.